| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,934 |
23,596 |
$4.73M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,163 |
21,181 |
$4.12M |
| G0378 |
Hospital observation service, per hour |
3,461 |
1,900 |
$2.89M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,892 |
8,473 |
$1.44M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,407 |
1,310 |
$170K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,354 |
1,316 |
$168K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,625 |
1,601 |
$142K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,553 |
818 |
$135K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,186 |
1,157 |
$72K |
| 36000 |
|
1,455 |
1,374 |
$62K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,063 |
13,738 |
$47K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
362 |
357 |
$44K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,266 |
1,246 |
$29K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,513 |
1,443 |
$26K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,317 |
1,135 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
2,125 |
2,046 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,383 |
5,732 |
$19K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,156 |
4,816 |
$18K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
318 |
317 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,256 |
14,376 |
$17K |
| 76830 |
Ultrasound, transvaginal |
379 |
371 |
$16K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,239 |
4,080 |
$14K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
126 |
44 |
$14K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
410 |
394 |
$13K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,947 |
1,896 |
$13K |
| 97161 |
|
137 |
128 |
$11K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
168 |
165 |
$9K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
922 |
868 |
$9K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
484 |
471 |
$9K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
74 |
73 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
484 |
446 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,950 |
1,656 |
$6K |
| 0001A |
|
130 |
130 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
173 |
170 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
2,556 |
2,413 |
$6K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
52 |
51 |
$6K |
| 84484 |
|
3,213 |
2,750 |
$6K |
| 0002A |
|
103 |
103 |
$6K |
| 71250 |
|
103 |
99 |
$5K |
| 70486 |
|
205 |
202 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
162 |
127 |
$5K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
58 |
26 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
16 |
16 |
$5K |
| 73630 |
|
566 |
516 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,075 |
1,828 |
$4K |
| 72100 |
|
185 |
177 |
$4K |
| 80076 |
|
2,763 |
2,605 |
$4K |
| 93971 |
|
136 |
131 |
$4K |
| T1015 |
Clinic visit/encounter, all-inclusive |
59 |
14 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
178 |
170 |
$3K |
| 73030 |
|
332 |
318 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
166 |
164 |
$3K |
| 76801 |
|
153 |
141 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
410 |
394 |
$3K |
| 93975 |
|
77 |
76 |
$3K |
| 73130 |
|
454 |
414 |
$3K |
| 73562 |
|
128 |
103 |
$2K |
| 73564 |
|
349 |
330 |
$2K |
| 90715 |
|
530 |
521 |
$2K |
| 73610 |
|
341 |
316 |
$2K |
| 80320 |
|
427 |
392 |
$2K |
| 93017 |
|
53 |
52 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
101 |
99 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
770 |
700 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
499 |
266 |
$2K |
| 76770 |
|
31 |
31 |
$2K |
| 83690 |
|
2,192 |
2,067 |
$2K |
| 85730 |
|
1,300 |
1,218 |
$2K |
| 12001 |
|
39 |
38 |
$2K |
| 12002 |
|
13 |
13 |
$2K |
| 83735 |
|
1,682 |
1,429 |
$2K |
| 81003 |
|
1,985 |
1,877 |
$1K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
95 |
88 |
$1K |
| 0031A |
|
29 |
29 |
$1K |
| 84702 |
|
411 |
385 |
$1K |
| A9270 |
Non-covered item or service |
19,643 |
6,538 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
423 |
392 |
$1K |
| 80053 |
Comprehensive metabolic panel |
645 |
587 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27 |
24 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
234 |
223 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
13 |
$1K |
| 80329 |
|
323 |
292 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
68 |
63 |
$1K |
| 83880 |
|
327 |
315 |
$990.39 |
| 85610 |
|
1,363 |
1,274 |
$961.69 |
| 82805 |
|
181 |
168 |
$872.59 |
| 83605 |
|
716 |
649 |
$803.77 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
383 |
376 |
$784.28 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
434 |
429 |
$745.20 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
28 |
28 |
$700.98 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
386 |
363 |
$632.19 |
| 85379 |
|
468 |
446 |
$575.53 |
| 87631 |
|
134 |
133 |
$570.50 |
| 73502 |
|
43 |
42 |
$547.86 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
434 |
429 |
$530.04 |
| 96376 |
|
709 |
526 |
$526.40 |
| 81001 |
|
1,289 |
1,260 |
$524.35 |
| 82962 |
|
1,053 |
707 |
$502.78 |
| 87186 |
|
263 |
258 |
$502.17 |
| 76775 |
|
15 |
13 |
$491.17 |
| 86850 |
|
299 |
287 |
$479.62 |
| 73110 |
|
123 |
120 |
$465.55 |
| 84703 |
|
326 |
312 |
$463.89 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
136 |
106 |
$434.44 |
| 72110 |
|
24 |
24 |
$398.91 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,814 |
1,444 |
$384.22 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,362 |
1,150 |
$370.07 |
| 87040 |
|
141 |
122 |
$364.00 |
| 82550 |
|
371 |
337 |
$359.63 |
| 87088 |
|
325 |
316 |
$356.80 |
| 86900 |
|
381 |
365 |
$348.13 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
171 |
166 |
$341.41 |
| 86901 |
|
377 |
361 |
$303.23 |
| 85027 |
|
371 |
309 |
$256.43 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
17 |
16 |
$229.61 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
64 |
41 |
$227.00 |
| 87070 |
|
75 |
68 |
$173.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,985 |
5,426 |
$158.13 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
81 |
76 |
$136.53 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
202 |
195 |
$127.61 |
| 87210 |
|
181 |
178 |
$98.94 |
| 84100 |
|
225 |
165 |
$91.25 |
| 80061 |
Lipid panel |
118 |
110 |
$87.99 |
| J2704 |
Injection, propofol, 10 mg |
98 |
87 |
$82.15 |
| 82010 |
|
82 |
72 |
$81.50 |
| J1953 |
Injection, levetiracetam, 10 mg |
19 |
15 |
$73.40 |
| 36415 |
Collection of venous blood by venipuncture |
611 |
451 |
$70.38 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,955 |
2,569 |
$66.60 |
| J3490 |
Unclassified drugs |
1,944 |
1,519 |
$62.71 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
145 |
135 |
$58.19 |
| 73590 |
|
13 |
13 |
$49.50 |
| J1815 |
Injection, insulin, per 5 units |
1,426 |
566 |
$48.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,234 |
1,047 |
$48.05 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
524 |
472 |
$42.08 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
233 |
157 |
$39.02 |
| 84460 |
|
14 |
14 |
$36.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
506 |
460 |
$35.93 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
725 |
635 |
$35.13 |
| 82247 |
|
15 |
15 |
$34.65 |
| J1245 |
Injection, dipyridamole, per 10 mg |
41 |
40 |
$32.76 |
| 84075 |
|
14 |
14 |
$31.85 |
| 82330 |
|
69 |
65 |
$29.47 |
| 82248 |
|
12 |
12 |
$27.72 |
| J2060 |
Injection, lorazepam, 2 mg |
576 |
478 |
$24.78 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,241 |
1,011 |
$23.83 |
| 84155 |
|
15 |
15 |
$23.35 |
| 73080 |
|
18 |
18 |
$23.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
159 |
95 |
$22.48 |
| J1644 |
Injection, heparin sodium, per 1000 units |
242 |
123 |
$19.57 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
814 |
511 |
$18.74 |
| 82040 |
|
15 |
15 |
$18.25 |
| 86140 |
|
82 |
72 |
$18.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
576 |
554 |
$17.50 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
49 |
26 |
$14.67 |
| 84295 |
|
67 |
63 |
$13.19 |
| 84132 |
|
69 |
65 |
$12.87 |
| 82435 |
|
67 |
63 |
$12.87 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
112 |
98 |
$12.04 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
117 |
93 |
$10.55 |
| 87205 |
|
18 |
16 |
$9.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
42 |
38 |
$6.96 |
| 82947 |
|
69 |
65 |
$4.12 |
| 85651 |
|
15 |
13 |
$3.77 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
123 |
113 |
$3.41 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
199 |
172 |
$2.63 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
224 |
160 |
$2.43 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
17 |
15 |
$0.48 |
| 91300 |
|
45 |
43 |
$0.06 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
163 |
144 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
175 |
121 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
29 |
26 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
15 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
175 |
131 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
271 |
220 |
$0.00 |
| 81025 |
|
45 |
45 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
38 |
12 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
40 |
40 |
$0.00 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
24 |
24 |
$0.00 |